$125 | Single User
$250 | Site License
$375 | Global License

Apotex Inc - Strategic SWOT Analysis Review [Report Updated: 31-01-2019]

Published by Global Data: 31 Jan 2019 | 230729 | In Stock

Introduction

Apotex Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.

- Corporate strategy – GlobalData’s summarization of the company’s business strategy.

- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.

- Company history – Progression of key events associated with the company.

- Major products and services – A list of major products, services and brands of the company.

- Key competitors – A list of key competitors to the company.

- Key employees – A list of the key executives of the company.

- Executive biographies – A brief summary of the executives’ employment history.

- Key operational heads – A list of personnel heading key departments/functions.

- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Apotex Inc (Apotex) produces and markets a wide range of generic pharmaceuticals. The company also offers biosimilars, active pharmaceutical ingredients and pharmaceuticals. It carries out the research, development, manufacture and distribution of non-prescription and private label medicines, fine chemicals and disposable plastics for medical use. The company has research and development (R&D) facilities in Montreal, Richmond Hill, Brantford, Windsor, Winnipeg, Toronto, Etobicoke, Mississauga, London, Calgary and Vancouver. It serves patients, healthcare providers and payers, governments and other pharmaceutical manufacturers. It operates through subsidiaries, joint ventures and licensing agreements across Americas, Europe, the Middle East, Africa and Asia-Pacific. Apotex is headquartered in Toronto, Ontario, Canada.

Apotex Inc Key Recent Developments

Dec 19,2018: Apotex names Jeff Watson as leader after CEO Jack Kay departs

Aug 10,2018: FDA approves first generic drug under new CGT designation

Aug 08,2018: CannTrust and Apotex accelerate partnership to fuel global expansion in medical cannabis market

May 09,2018: Apotex Announces Proposed Merger of AUS & NZ Operations

Mar 08,2018: Advisory - Chipped pills in additional packages of Alysena 21 and 28 birth control pills

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.

- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Table of Contents
for Apotex Inc - Strategic SWOT Analysis Review [Report Updated: 31-01-2019]

  • Table of Contents

    Table of Contents 3

    List of Tables 4

    List of Figures 4

    Section 1 - About the Company 5

    Apotex Inc - Key Facts 5

    Apotex Inc - Key Employees 6

    Apotex Inc - Key Employee Biographies 7

    Apotex Inc - Major Products and Services 8

    Apotex Inc - History 10

    Apotex Inc - Company Statement 12

    Apotex Inc - Locations And Subsidiaries 13

    Head Office 13

    Other Locations & Subsidiaries 13

    Section 2 – Company Analysis 15

    Company Overview 15

    Apotex Inc - Business Description 16

    Apotex Inc - SWOT Analysis 17

    SWOT Analysis - Overview 17

    Apotex Inc - Strengths 17

    Apotex Inc - Weaknesses 18

    Apotex Inc - Opportunities 19

    Apotex Inc - Threats 20

    Apotex Inc - Key Competitors 21

    Section 3 – Company’s Lifesciences Financial Deals and Alliances 22

    Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 22

    Apotex Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 23

    Apotex Inc, Recent Deals Summary 24

    Section 4 – Company’s Recent Developments 25

    Aug 10, 2018: FDA approves first generic drug under new CGT designation 25

    Aug 08, 2018: CannTrust and Apotex accelerate partnership to fuel global expansion in medical cannabis market 26

    May 09, 2018: Apotex Announces Proposed Merger of AUS & NZ Operations 27

    Mar 08, 2018: Advisory - Chipped pills in additional packages of Alysena 21 and 28 birth control pills 28

    Section 5 – Appendix 29

    Methodology 29

    About GlobalData 29

    Contact Us 29

    Disclaimer 29

List Of Tables
in Apotex Inc - Strategic SWOT Analysis Review [Report Updated: 31-01-2019]

List of Tables

Apotex Inc, Key Facts 5

Apotex Inc, Key Employees 6

Apotex Inc, Key Employee Biographies 7

Apotex Inc, Major Products and Services 8

Apotex Inc, History 10

Apotex Inc, Subsidiaries 13

Apotex Inc, Key Competitors 21

Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 22

Apotex Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 23

Apotex Inc, Recent Deals Summary 24

List Of Figures, Charts and Diagrams
in Apotex Inc - Strategic SWOT Analysis Review [Report Updated: 31-01-2019]

List of Figures

Apotex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 22

Apotex Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019 23

Additional Details

Publisher

Global Data

Publisher Information

Reference

230729 | GDPH6309SA

Number of Pages

29

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Apotex Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryApotex Inc (Apotex) produces and markets a wide range of generic pharmaceuticals. It also und...
13 Nov 2018 by Global Data USD $250 More Info
Apotex, Inc. - Strategy, SWOT and Corporate Finance Report
SummaryApotex, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive comp...
28 Dec 2016 by Marketline USD $175 More Info
Apotex Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryApotex Inc (Apotex) is a pharmaceutical company that carries out the production and marketing...
22 Nov 2016 by Global Data USD $250 More Info
Apotex Partnering Deals and Alliances 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Nov 2016 by Current Partnering USD $1,495 More Info
Apotex, Inc. - Strategy, SWOT and Corporate Finance Report
SummaryApotex, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive comp...
21 Oct 2016 by Marketline USD $175 More Info
Apotex Partnering Deals and Alliances 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Apotex Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryApotex Inc. (Apotex) is a pharmaceutical company that carries out the production and marketin...
29 Jul 2016 by Global Data USD $250 More Info
Apotex, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
SummaryMarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments r...
15 Apr 2016 by Marketline USD $350 More Info
Apotex Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryApotex Inc. (Apotex) is a pharmaceutical company that carries out the production and marketin...
05 Apr 2016 by Global Data USD $250 More Info
Apotex Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryApotex Inc. (Apotex) is a pharmaceutical company that carries out the production and marketin...
03 Mar 2016 by Global Data USD $250 More Info

This report is published by Global Data

Download Free Report Summary PDF

Apotex Inc - Strategic SWOT Analysis Review [Report Updated: 31-01-2019] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data